• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX TRIFOCAL HYDROPHOBIC INTRAOCULAR LENS; LENS, MULTIFOCAL INTRAOCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX TRIFOCAL HYDROPHOBIC INTRAOCULAR LENS; LENS, MULTIFOCAL INTRAOCULAR Back to Search Results
Model Number CNWTT0
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Dry Eye(s) (1814); Blurred Vision (2137); Visual Impairment (2138)
Date of Event 02/20/2023
Type of Reportable Event Serious Injury
Event or Problem Description
A nurse reported that following an intraocular lens (iol) implant procedure, the patient experienced distance vision blurry when driving and near vision also blurry.The patient has poor quality vision at all distances with and without correction.The lens was explanted in a secondary procedure.In the surgeon¿s opinion, iol did not cause or contribute to the event.The patient unable to adapt to diffractive optics.There was no patient harm and patient much happier with visual quality with monofocal iol.
 
Additional Manufacturer Narrative
The product was not returned for analysis.The root cause for the reported complaint could not be determined as no sample was returned for analysis.Based on the results from the product history record, the products met release criteria.The manufacturer internal reference number is: (b)(4).
 
Additional Manufacturer Narrative
The product was not returned for analysis.User facility reported that according to the surgeon, the iol did not cause the event.Event was related to patient unable to adapt to diffractive optics.The root cause for the reported complaint appears to be a coincidental event that was unrelated to the product as user facility reported that according to the surgeon, the iol did not cause the event.Event was related to patient unable to adapt to diffractive optics.Based on this information, the device did not cause/contribute to the event.Based on the results from the product history record, the products met release criteria the manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON PANOPTIX TRIFOCAL HYDROPHOBIC INTRAOCULAR LENS
Common Device Name
LENS, MULTIFOCAL INTRAOCULAR
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key16683839
Report Number9612169-2023-00262
Device Sequence Number17965195
Product Code MFK
UDI-Device Identifier00380652408004
UDI-Public00380652408004
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2023
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Nurse
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 05/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/10/2026
Device Model NumberCNWTT0
Device Catalogue NumberCNWTT0.140
Device Lot Number25341494
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/08/2023
Supplement Date Received by Manufacturer05/16/2023
Initial Report FDA Received Date04/05/2023
Supplement Report FDA Received Date05/25/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured01/12/2022
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MONARCH III CARTRIDGE D.; MONARCH III INJECTOR.; PROVISC.
Outcome Attributed to Adverse Event Required Intervention;
Patient Age63 YR
Patient SexMale
-
-